COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,187 Articles (22,713 medRxiv, 8,474 bioRxiv)

Most recent first Previous |  Page 1241: Articles 12401-12410  | Next

The evolutionary landscape of SARS-CoV-2 variant B.1.1.519 and its clinical impact in Mexico City
Cedro-Tanda, A., Gomez-Romero, L., Alcaraz, N., de Anda-Jauregui, G., Penaloza, F., Moreno, B., Escobar-Arrazola, M. A., Ramirez-Vega, O. A., Cisneros-Villanueva, M., Moreno-Camacho, J. L., Rodriguez-Gallegos, J., Luna-Ruiz Esparza, M. A., Fernandez-Rojas, M. A., Mendoza-Vargas, A., Reyes-Grajeda, J. P., Campos-Romero, A., Angulo, O., Ruiz, R., Sheinbaum-Pardo, C., Sifuentes-Osornio, J., Kershenobich, D., Hidalgo-Miranda, A., Herrera, L. A.
10.1101/2021.09.07.21262911 — Posted: 2021-09-14 Discussion: Onsite
Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation
Huang, Y., Borisov, O., Kee, J. J., Carpp, L. N., Wrin, T., Cai, S., Sarzotti-Kelsoe, M., McDanal, C., Eaton, A., Pajon, R., Hural, J., Posavad, C. M., Gill, K., Karuna, S., Corey, L., McElrath, M. J., Gilbert, P. B., Petropoulos, C. J., Montefiori, D. C.
10.1101/2021.09.09.21263049 — Posted: 2021-09-14
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity.
Fallerini, C., Picchiotti, N., Baldassarri, M., Zguro, K., Daga, S., Fava, F., Benetti, E., Amitrano, S., Bruttini, M., Palmieri, M., Croci, S., Lista, M., Beligni, G., Valentino, F., Meloni, I., Tanfoni, M., Colombo, F., Cabri, E., Fratelli, M., Gabbi, C., Mantovani, S., Frullanti, E., Gori, M., Crawley, F. P., Butler-Laporte, G., Richards, B., Zeberg, H., Lipcsey, M., Hultstrom, M., Ludwig, K. U., Schulte, E. C., Pairo-Castineira, E., Baillie, J. K., Schmidt, A., Frithiof, R., WES/WGS working group within the HGI, , GenOMICC Consortium, , GEN-COVID Multicenter Study, , Mari, F., Renieri, A., Furini, S.
10.1101/2021.09.03.21262611 — Posted: 2021-09-14
COVID-19 Bimodal Clinical and Pathological Phenotypes
Batah, S., Benatti, M., Siyuan, L., Telini, W., Barbosa, J., Menezes, M., Nadai, T., S, K., Vaswani, C., Gupta, S., Zamboni, D., Wada, D., Calado, R., Oliveira, R., Louzada-Junior, P., Auxiliadora-Martins, M., Veras, F., Cunha, L., Cunha, T., Luppino-Assad, R., Balancin, M., Morais, S., Martins, R., Arruda, E., Chahud, F., Koenigkam-Santos, M., Cetlin, A., Cunha, F., Santos, C., Capelozzi, V., Fukuoka, J., Duarte-Achcar, R., Fabro, A.
10.1101/2021.09.03.21262841 — Posted: 2021-09-14
Place, cause and expectedness of death and relationship to the deceased are associated with poorer experiences of end-of-life care and challenges in early bereavement: Risk factors from an online survey of people bereaved during the COVID-19 pandemic
Selman, L. E., Farnell, D. J., Longo, M., Goss, S., Seddon, K., Torrens-Burton, A., Mayland, C. R., Wakefield, D., Johnston, B., Byrne, A., Harrop, E. J.
10.1101/2021.09.09.21263341 — Posted: 2021-09-14
CHARACTERIZING AND MANAGING AN EPIDEMIC: A FIRST PRINCIPLES MODEL AND A CLOSED FORM SOLUTION TO THE KERMACK AND MCKENDRICK EQUATIONS
Duclos, T. G., Reichert, T. A.
10.1101/2021.09.09.21263355 — Posted: 2021-09-14
Antibody responses to BNT162b2 mRNA vaccine: infection-naive individuals with abdominal obesity warrant attention
MALAVAZOS, A. E., Basilico, S., Iacobellis, G., Milani, V., Cardani, R., Boniardi, F., Dubini, C., Prandoni, I., Capitanio, G., Renna, L. V., Boveri, S., Carrara, M., Spuria, G., Cuppone, M. T., D'Acquisto, A., Carpinelli, L., Sacchi, M., Morricone, L., Secchi, F., Costa, E., Menicanti, L., Nisoli, E., Carruba, M. O., Ambrogi, F., Corsi Romanelli, M. M.
10.1101/2021.09.10.21262710 — Posted: 2021-09-14 Discussion: Onsite
SARS-COV2 mutant-specific T cells and neutralizing antibodies after vaccination and up to 1 year after infection
Richardson, J. R., Goetz, R., Mayr, V., Lohse, M. J., Holthoff, H.-P., Ungerer, M.
10.1101/2021.09.07.21262725 — Posted: 2021-09-14 Discussion: Onsite
Analytical performances of the COVISTIX and Panbio antigen rapid tests for SARS-CoV-2 detection in an unselected population (all commers)
Garcia-Cardenas, F., Franco, A., Cortes, R., Bertin, J., Valdez, R., Penaloza, F., Frias-Jimenez, E., Cedro-Tanda, A., Mendoza-Vargas, A., Reyes-Grajeda, J. P., Hidalgo-Miranda, A., Herrera, L. A.
10.1101/2021.09.10.21263410 — Posted: 2021-09-14
SARS-CoV-2 serology across scales: a framework for unbiased seroprevalence estimation incorporating antibody kinetics and epidemic recency
Takahashi, S., Peluso, M. J., Hakim, J., Turcios, K., Janson, O., Routledge, I., Busch, M. P., Hoh, R., Tai, V., Kelly, J. D., Martin, J. N., Deeks, S. G., Henrich, T. J., Greenhouse, B., Rodriguez-Barraquer, I.
10.1101/2021.09.09.21263139 — Posted: 2021-09-14 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).